Qianyuan Pharmaceutical (300254.SZ) announced 2024 annual results, with net profit of 42.191 million yuan to mother, an increase of 67.45%

Zhitongcaijing · 04/14 13:49

According to the Zhitong Finance App, Qianyuan Pharmaceutical (300254.SZ) released its 2024 annual report. The company's revenue was 847 million yuan, an increase of 5.92% over the previous year. Net profit attributable to shareholders of listed companies was 42.1901 million yuan, an increase of 67.45% year over year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 25.22,700. Basic earnings per share were $0.1746.